APA (7th ed.) Citation

S, K., T, T., K, K., Y, T., K, K., Y, T., & M, S. (2026). Drug-induced Interstitial Lung Disease with a Hypersensitivity Pneumonitis Pattern Following Pembrolizumab Plus Epirubicin and Cyclophosphamide Therapy: First Report with Pathological Findings. Internal medicine (Tokyo, Japan), 65(11), 1514. https://doi.org/10.2169/internalmedicine.6290-25

Chicago Style (17th ed.) Citation

S, Kaburaki, Tanaka T, Kamio K, Tanaka Y, Kasahara K, Terasaki Y, and Seike M. "Drug-induced Interstitial Lung Disease with a Hypersensitivity Pneumonitis Pattern Following Pembrolizumab Plus Epirubicin and Cyclophosphamide Therapy: First Report with Pathological Findings." Internal Medicine (Tokyo, Japan) 65, no. 11 (2026): 1514. https://doi.org/10.2169/internalmedicine.6290-25.

MLA (9th ed.) Citation

S, Kaburaki, et al. "Drug-induced Interstitial Lung Disease with a Hypersensitivity Pneumonitis Pattern Following Pembrolizumab Plus Epirubicin and Cyclophosphamide Therapy: First Report with Pathological Findings." Internal Medicine (Tokyo, Japan), vol. 65, no. 11, 2026, p. 1514, https://doi.org/10.2169/internalmedicine.6290-25.